APA (7th ed.) Citation

White, M., Haddad, H., Leblanc, M., Giannetti, N., Pflugfelder, P., Davies, R., . . . Ross, H. (2005). Conversion From Cyclosporine Microemulsion to Tacrolimus-Based Immunoprophylaxis Improves Cholesterol Profile in Heart Transplant Recipients With Treated but Persistent Dyslipidemia: The Canadian Multicentre Randomized Trial of Tacrolimus vs Cyclosporine Microemulsion. Journal of Heart & Lung Transplantation, 24(7), 798. https://doi.org/10.1016/j.healun.2004.05.023

Chicago Style (17th ed.) Citation

White, Michel, et al. "Conversion From Cyclosporine Microemulsion to Tacrolimus-Based Immunoprophylaxis Improves Cholesterol Profile in Heart Transplant Recipients With Treated but Persistent Dyslipidemia: The Canadian Multicentre Randomized Trial of Tacrolimus Vs Cyclosporine Microemulsion." Journal of Heart & Lung Transplantation 24, no. 7 (2005): 798. https://doi.org/10.1016/j.healun.2004.05.023.

MLA (9th ed.) Citation

White, Michel, et al. "Conversion From Cyclosporine Microemulsion to Tacrolimus-Based Immunoprophylaxis Improves Cholesterol Profile in Heart Transplant Recipients With Treated but Persistent Dyslipidemia: The Canadian Multicentre Randomized Trial of Tacrolimus Vs Cyclosporine Microemulsion." Journal of Heart & Lung Transplantation, vol. 24, no. 7, 2005, p. 798, https://doi.org/10.1016/j.healun.2004.05.023.